Shares of (HCC) fell roughly 9% on December 5 after the stock went ex‑rights ahead of its ₹1,000 crore rights issue. The firm will issue nearly 80 crore new shares at ₹12.50 each, a steep discount that dilutes existing equity. Value per share adjusts downward automatically so long‑term investors should focus on post‑issue fundamentals, not the mechanical price drop.